Overview
Overview
Understanding an individual's metabolome, combined with their medical history and lifestyle, allows clinicians to establish a larger picture and provide support from the bottom up. Ideally, practitioners will use OMX to establish a baseline metabolic signature for healthy patients. The baseline could be used for future comparison if symptoms, disease, or illness occurs.
Analytes
Metabolic processing
| Nutrition
| Amino acid and Protein Metabolism
|
Toxic Impacts 8-Hydroxy-2'-deoxyguanosine | Stress and Mood Amino butiric Acid Microbial Metabolites 4-Hydroxyphenylacetic Acid |
Methodology
LC-MS/MS
Indications
The OMX™ Organic Metabolomics test evaluates urine metabolites—including organic acids, amino acids, and other key compounds—to assist practitioners in unraveling their patient’s metabolic pathways, revealing their unique Metabolic Signature.
OMX™ metabolomic testing goes beyond traditional organic acid testing. OMX characterizes metabolic phenotypes by presenting analytes in pathway categories to more easily identify metabolomic deviations that can underlie—and even precede—disease
Indications
- Mood Disorders
- Mitochondrial Dysfunction
- Fatigue
- Chronic Stress
- Inflammation
- Depression,
- Cardiovascular disease,
- Neurocognitive decline
- Diabetes
Practical
Specimen
Urine
Please be aware that urine sampling is representative of recent dietary intake and metabolism of amino acids, it is more variable than in plasma. It is useful for controlled diets or to assess for efficacy of recent dietary changes (typically last 24/48 hours). Amino acid levels in urine can be influenced by abnormal kidney function and is ideal for children and adults as it is conveniently collected at home.
Container
Yellow capped Cup
Patient preparation
- Avoid consuming fruits, jams, and jellies for 48 hours prior to collection
Downloads
16-Dec-2024
16-Dec-2024
31-May-2023
18-May-2022
Research
- U.S. Department of Health and Human Services. (2016, March 9). Metabolomics Overview. National Institutes of Health. Retrieved November 23, 2021
- Hood, L. as cited in Miller, I.J., Peters, S.R., Overmyer, K.A. et al. Real-time health monitoring through urine metabolomics. npj Digit. Med. 2, 109 (2019).
- Beger RD, Dunn W, Schmidt MA, et al. Metabolomics enables precision medicine: "A White Paper, Community Perspective". Metabolomics. 2016;12(10):149.